Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression.

Singh AB, Bousman CA, Ng CH, Byron K, Berk M.

Transl Psychiatry. 2012 Nov 27;2:e198. doi: 10.1038/tp.2012.115.

2.

Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression.

Ng C, Sarris J, Singh A, Bousman C, Byron K, Peh LH, Smith DJ, Tan CH, Schweitzer I.

Hum Psychopharmacol. 2013 Sep;28(5):516-22. doi: 10.1002/hup.2340.

PMID:
24014145
3.

ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.

Schatzberg AF, DeBattista C, Lazzeroni LC, Etkin A, Murphy GM Jr, Williams LM.

Am J Psychiatry. 2015 Aug 1;172(8):751-9. doi: 10.1176/appi.ajp.2015.14050680. Epub 2015 Mar 27.

PMID:
25815420
4.

Association between the functional polymorphism (C3435T) of the gene encoding P-glycoprotein (ABCB1) and major depressive disorder in the Japanese population.

Fujii T, Ota M, Hori H, Sasayama D, Hattori K, Teraishi T, Yamamoto N, Hashikura M, Tatsumi M, Higuchi T, Kunugi H.

J Psychiatr Res. 2012 Apr;46(4):555-9. doi: 10.1016/j.jpsychires.2012.01.012. Epub 2012 Feb 4.

PMID:
22306099
5.

Influence of ABCB1 polymorphisms and serum concentrations on venlafaxine response in patients with major depressive disorder.

Ozbey G, Celikel FC, Cumurcu BE, Kan D, Yucel B, Hasbek E, Percin F, Guzey IC, Uluoglu C.

Nord J Psychiatry. 2017 Apr;71(3):230-237. doi: 10.1080/08039488.2016.1268203. Epub 2017 Jan 12.

PMID:
28079463
6.

Association between serotonin transporter-linked polymorphic region and escitalopram antidepressant treatment response in Korean patients with major depressive disorder.

Won ES, Chang HS, Lee HY, Ham BJ, Lee MS.

Neuropsychobiology. 2012;66(4):221-9. doi: 10.1159/000341876. Epub 2012 Oct 20.

PMID:
23095326
7.

ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment.

Lin KM, Chiu YF, Tsai IJ, Chen CH, Shen WW, Liu SC, Lu SC, Liu CY, Hsiao MC, Tang HS, Liu SI, Chang LH, Wu CS, Tsou HH, Tsai MH, Chen CY, Wang SM, Kuo HW, Hsu YT, Liu YL.

Pharmacogenet Genomics. 2011 Apr;21(4):163-70. doi: 10.1097/FPC.0b013e32833db216.

PMID:
20859246
8.

ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.

Kato M, Fukuda T, Serretti A, Wakeno M, Okugawa G, Ikenaga Y, Hosoi Y, Takekita Y, Mandelli L, Azuma J, Kinoshita T.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):398-404. Epub 2007 Sep 15.

PMID:
17913323
9.

Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot study.

Nikisch G, Eap CB, Baumann P.

Pharmacol Res. 2008 Nov-Dec;58(5-6):344-7. doi: 10.1016/j.phrs.2008.09.010. Epub 2008 Sep 30.

PMID:
18940259
10.

ABCB1 C3435T polymorphism is associated with susceptibility to major depression, but not with a clinical response to citalopram in a Turkish population.

Ozbey G, Yucel B, Taycan SE, Kan D, Bodur NE, Arslan T, Percin F, Yuksel N, Guzey C, Uluoglu C.

Pharmacol Rep. 2014 Apr;66(2):235-8. doi: 10.1016/j.pharep.2013.09.004. Epub 2014 Mar 2.

PMID:
24911075
11.

Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.

Kennedy SH, Andersen HF, Lam RW.

J Psychiatry Neurosci. 2006 Mar;31(2):122-31. Erratum in: J Psychiatry Neurosci. 2006 Jul;31(4):228.

12.

ABCB1 gene variants and antidepressant treatment outcome: A meta-analysis.

Breitenstein B, Brückl TM, Ising M, Müller-Myhsok B, Holsboer F, Czamara D.

Am J Med Genet B Neuropsychiatr Genet. 2015 Jun;168B(4):274-83. doi: 10.1002/ajmg.b.32309. Epub 2015 Apr 2.

PMID:
25847751
13.

P-glycoprotein (PGP) polymorphisms and sexual dysfunction in female patients with depression and SSRI-associated sexual side effects.

Bly MJ, Bishop JR, Thomas KL, Ellingrod VL.

J Sex Marital Ther. 2013;39(3):280-8. doi: 10.1080/0092623X.2011.615896. Epub 2013 Jan 28.

14.

ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression.

Ray A, Tennakoon L, Keller J, Sarginson JE, Ryan HS, Murphy GM, Lazzeroni LC, Trivedi MH, Kocsis JH, DeBattista C, Schatzberg AF.

Pharmacogenomics J. 2015 Aug;15(4):332-9. doi: 10.1038/tpj.2014.72. Epub 2014 Dec 9.

PMID:
25487678
15.
16.

Association of ABCB1 gene variants, plasma antidepressant concentration, and treatment response: Results from a randomized clinical study.

Breitenstein B, Scheuer S, Brückl TM, Meyer J, Ising M, Uhr M, Holsboer F.

J Psychiatr Res. 2016 Feb;73:86-95. doi: 10.1016/j.jpsychires.2015.11.010. Epub 2015 Nov 24.

PMID:
26704739
17.

Serotonin transporter gene polymorphism associated with short-term treatment response to venlafaxine.

Lee SH, Choi TK, Lee E, Seok JH, Lee SH, Lee HS, Kim SJ.

Neuropsychobiology. 2010 Aug;62(3):198-206. doi: 10.1159/000319362. Epub 2010 Jul 22.

18.

Case-control association study of ABCB1 gene and major depressive disorder in a local Chinese Han population.

Xie WW, Zhang L, Wu RR, Yu Y, Zhao JP, Li LH.

Neuropsychiatr Dis Treat. 2015 Aug 4;11:1967-71. doi: 10.2147/NDT.S87175. eCollection 2015.

19.
20.

ABCB6, ABCB1 and ABCG1 genetic polymorphisms and antidepressant response of SSRIs in Chinese depressive patients.

Huang X, Yu T, Li X, Cao Y, Li X, Liu B, Yang F, Li W, Zhao X, Feng G, Zhang X, Dong Z, He L, Sun X, He G.

Pharmacogenomics. 2013 Nov;14(14):1723-30. doi: 10.2217/pgs.13.151.

PMID:
24192121

Supplemental Content

Support Center